• LY2109761: Transforming TGF-β Dual Inhibition for Translatio

  2026-06-10

  Explore the mechanistic power, strategic applications, and translational promise of LY2109761, a dual TGF-β receptor type I and II kinase inhibitor. This article offers in-depth insights for researchers aiming to modulate Smad2/3 phosphorylation, overcome resistance in aggressive tumors, and design next-generation studies in cancer and fibrosis.

• Cy5 Hydrazide (Non-Sulfonated): Precision Tools for Redox Pr

  2026-06-10

  Cy5 hydrazide, a leading carbonyl-reactive fluorescent dye, is transforming redox proteomics and nanoparticle bioanalytics. Discover its distinct chemical properties and practical workflow advantages for sensitive protein carbonylation labeling and beyond.

• FXR Proteins and LLPS Drive β-Coronavirus Replication Organe

  2026-06-09

  This study uncovers that fragile X–related (FXR) proteins, through liquid–liquid phase separation (LLPS), are essential for the clustering of double-membrane vesicles (DMVs) that serve as replication organelles in β-coronavirus-infected cells. By elucidating how viral proteins hijack host phase separation machinery, the work provides a mechanistic foundation for understanding SARS-CoV-2 replication and suggests new strategies for targeting viral proliferation.

• TBST (Tris-Buffered Saline and Tween 20): Technical Workflow

  2026-06-09

  TBST (Tris-Buffered Saline and Tween 20) addresses high background and nonspecific binding in immunoassays by serving as a reliable, isotonic blocking and washing buffer. It is best suited for Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but should be avoided in protocols sensitive to non-ionic detergents.

• CAY10499: Inhibitor of Human Hormone Sensitive Lipase for Li

  2026-06-08

  CAY10499, a potent and selective inhibitor of human hormone sensitive lipase (HSL) and monoglyceride lipase (MGL), empowers researchers to dissect lipid-driven immunometabolic pathways with precision. Its robust performance in lipid metabolism assays and compatibility with complex tumor microenvironment models make it an essential reagent for investigating immune-metabolic cross-talk in cancer and metabolic diseases.

• Biotin Azide for Precision Biotinylation: Protocols & Innova

  2026-06-08

  Biotin Azide enables robust, bio-orthogonal labeling of alkynylated biomolecules through copper-catalyzed click chemistry, streamlining affinity purification and detection workflows. This guide details best practices, troubleshooting strategies, and key insights from novel cholesterol-Wnt signaling research, positioning APExBIO’s Biotin-azide as a benchmark reagent for sensitive, reproducible molecular biology applications.

• Patient-Derived Gastric Cancer Assembloids Advance Tumor Mod

  2026-06-07

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal subpopulations, enabling more physiologically relevant preclinical drug testing. The approach reveals how stromal context modulates gene expression and drug response, offering new insights for personalized cancer therapy development.

• RNA Polymerase II Degradation Drives Oocyte Chromatin Remode

  2026-06-06

  This study uncovers that targeted degradation of RNA polymerase II is both necessary and sufficient for the reorganization of oocyte chromatin from a transcriptionally active to a silent state. These findings clarify a longstanding question in developmental biology and provide a mechanistic framework for understanding the maternal-to-zygotic transition in mammals.

• Thiazovivin: ROCK Inhibitor for Stem Cell Workflow Optimizat

  2026-06-05

  Thiazovivin addresses two common challenges in stem cell research: low survival of human embryonic stem cells (hESCs) after dissociation and inefficient induced pluripotent stem cell (iPSC) generation from fibroblasts. It should be used strictly within research protocols requiring improved cell viability and reprogramming efficiency, and is not intended for diagnostic or clinical applications.

• Apigenin (N1828): Next-Generation HDAC Inhibition for Oncolo

  2026-06-05

  Explore the multifaceted utility of Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) as an advanced HDAC inhibitor for malignant mesothelioma and neurodegeneration research. This article uniquely integrates network medicine insights and in vivo data for precise, translational assay design.

• HDAC Inhibitors as NUT Function Repressors in NUT Carcinoma

  2026-06-04

  The referenced study identifies diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT-mediated transcriptional activation in NUT carcinoma, an aggressive squamous cancer subtype. By elucidating how HDAC inhibitors disrupt oncogenic chromatin megadomains, the research advances understanding of epigenetic vulnerabilities in this disease and highlights new therapeutic strategies.

• LG 101506: Advanced RXR Modulation for Immuno-Oncology Resea

  2026-06-04

  Discover how LG 101506, a high-purity RXR modulator, drives innovation in nuclear receptor signaling and immuno-oncology. This in-depth review reveals unique assay design strategies and actionable insights you won't find elsewhere.

• Leucovorin Calcium in Advanced Assembloid Drug Resistance Mo

  2026-06-03

  Leucovorin Calcium empowers translational researchers to dissect antifolate drug resistance in next-generation assembloid models, enabling precise folate pathway modulation and protection from methotrexate-induced cytotoxicity. This guide details experimental workflows, troubleshooting, and actionable insights for optimizing assembloid-based research using high-purity Leucovorin Calcium from APExBIO.

• Q-VD(OMe)-OPh (SKU A8165): Reproducible Caspase Inhibition i

  2026-06-03

  Discover how Q-VD(OMe)-OPh (SKU A8165) elevates experimental reliability in apoptosis, viability, and cytotoxicity assays. This scenario-driven guide details real laboratory challenges and evidence-based best practices for using this broad-spectrum pan-caspase inhibitor, ensuring robust data and workflow safety for biomedical researchers.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-06-02

  This study demonstrates that cannabidiol (CBD) significantly reduces both sensory and affective components of orofacial inflammatory pain in mice by modulating peripheral and central endocannabinoid pathways, including FAAH inhibition and anandamide elevation. The findings advance understanding of multi-modal analgesic mechanisms and highlight translational potential for comprehensive pain management strategies targeting the endocannabinoid system.

16037 records 1/1070 page Next 12345 下5页 Last page